Cognitive processes of apathy in Huntington’s disease show high sensitivity to disease progression

BACKGROUND: Disease-modifying treatments for Huntington’s disease (HD) are entering clinical trials: there is a pressing need for objective outcome measures of disease progression. Our previous work showed an association between 2 novel, objective cognitive tasks and apathy - a core feature of disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Hare, Emily, Bachoud-Lévi, Anne-Catherine, Reilmann, Ralf, Craufurd, David, Busse, Monica, Rosser, Anne, McLauchlan, Duncan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673112/
https://www.ncbi.nlm.nih.gov/pubmed/36405870
http://dx.doi.org/10.1016/j.prdoa.2022.100168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673112/
https://www.ncbi.nlm.nih.gov/pubmed/36405870
http://dx.doi.org/10.1016/j.prdoa.2022.100168

Ejemplares similares